LABFF vs MSFT: Which Stock is Better?

Side-by-side comparison of Laboratorios Farmaceuticos Rovi, S.A./Adr and Microsoft Corp in 2026

Comparison Updated:

LABFF

Laboratorios Farmaceuticos Rovi, S.A./Adr

$90.61

MSFT

Microsoft Corp

$422.50

Key Metrics Comparison

MetricLABFFMSFTWinner
Market Cap$4.63BN/ALABFF
P/E Ratio28.9526.31MSFT
EPS (TTM)$3.13$16.07MSFT
Revenue Growth0.1%0.2%MSFT
Gross Margin63.4%68.6%MSFT

Analyze LABFF

Full quant analysis

Analyze MSFT

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LABFF or MSFT a better investment?

Comparing LABFF and MSFT: Laboratorios Farmaceuticos Rovi, S.A./Adr has a market cap of $4.63B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LABFF and MSFT?

LABFF (Laboratorios Farmaceuticos Rovi, S.A./Adr) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LABFF or MSFT?

Based on P/E ratios, MSFT trades at a lower multiple (26.3x vs 28.9x).

Which is growing faster: LABFF or MSFT?

MSFT has higher revenue growth at 0.2% vs 0.1% for LABFF.

Which company is more profitable: LABFF or MSFT?

Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 63.4% for LABFF.

Which is the larger company: LABFF or MSFT?

Laboratorios Farmaceuticos Rovi, S.A./Adr (LABFF) is larger with a market cap of $4.63B compared to N/A for MSFT.

Should I buy LABFF or MSFT in 2026?

Both LABFF and MSFT have investment merit. LABFF trades at $90.61 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LABFF and MSFT stock?

Key differences: Market Cap ($4.63B vs N/A), P/E Ratio (28.9x vs 26.3x), Revenue Growth (0.1% vs 0.2%), Gross Margin (63.4% vs 68.6%).

Popular Stock Comparisons